BrainStorm | Hadassah International

BrainStorm currently conducts Second Phase ALS Studies at Hadassah – Test Results expected by July 2016

Research results of the studies completed so far show substantial improvement in the rate of progression of the ALSFRS-R (Amyotrophic Lateral Sclerosis Functional Rating Scale ratio, which is a predictor for the…

ALS Research

Stem Cell Treatment Inhibits ALS Disease Progression In 87% of Patients, according to clinical trial conducted by HMO and BrainStorm Cell Therapeutics

ALS Research

Researchers at Hadassah Stop the Progression of Amyotrophic Lateral Sclerosis (ALS)

ALS Research

Stem Cell Trial at Hadassah Reveals Significant Positive Results for ALS Patients

Stem Cell Research

New Hadassah Medical Center Clinical Trial Data Show Promise for Stem Cell Therapy in Treating ALS

ALS Research

FDA Approves Multi-Center US Clinical Trials to Treat ALS with Israel Stem Cell Technology

Stem Cell Research

BrainStorm Stem Cell Technology Administered at Hadassah Yields Major Therapeutic Results in Patient with ALS and Myasthenia Gravis

ALS Research

ALS Stem Cell Trial Yielding “Impressively Positive” Findings

ALS Research

Researchers at Hadassah ‬Stop the Progression of Amyotrophic Lateral Sclerosis (ALS)

ALS Research

BrainStorm Stem Cell Therapy for ALS is Fast-Tracked to New Phase

Parkinson's Disease

Rasheda Ali, Stem Cell Advocate and Muhammad Ali’s Daughter, Visits with Hadassah’s Neurology Experts

ALS Research

Hadassah Clinical Trial Reveals Safety and Efficacy of Stem Cell Technology in Treating ALS

ALS Research

Clinical Trial Using Adult Stem Cell Therapy to Treat ALS Begins at Hadassah University Medical Center

ALS Research

Hadassah International

BrainStorm currently conducts Second Phase ALS Studies at Hadassah – Test Results expected by July 2016

BrainStorm currently conducts Second Phase ALS Studies at Hadassah – Test Results expected by July 2016

Stem Cell Treatment Inhibits ALS Disease Progression In 87% of Patients, according to clinical trial conducted by HMO and BrainStorm Cell Therapeutics

Researchers at Hadassah Stop the Progression of Amyotrophic Lateral Sclerosis (ALS)

Stem Cell Trial at Hadassah Reveals Significant Positive Results for ALS Patients

New Hadassah Medical Center Clinical Trial Data Show Promise for Stem Cell Therapy in Treating ALS

FDA Approves Multi-Center US Clinical Trials to Treat ALS with Israel Stem Cell Technology

BrainStorm Stem Cell Technology Administered at Hadassah Yields Major Therapeutic Results in Patient with ALS and Myasthenia Gravis

ALS Stem Cell Trial Yielding “Impressively Positive” Findings

Researchers at Hadassah ‬Stop the Progression of Amyotrophic Lateral Sclerosis (ALS)

BrainStorm Stem Cell Therapy for ALS is Fast-Tracked to New Phase

Rasheda Ali, Stem Cell Advocate and Muhammad Ali’s Daughter, Visits with Hadassah’s Neurology Experts

Hadassah Clinical Trial Reveals Safety and Efficacy of Stem Cell Technology in Treating ALS

Clinical Trial Using Adult Stem Cell Therapy to Treat ALS Begins at Hadassah University Medical Center

Hadassah Medical Center Will Conduct Clinical Trial of Stem Cell Treatment for ALS